Cargando…

肺鳞癌肿瘤浸润前沿细胞的EMT表型特点及临床意义

BACKGROUND AND OBJECTIVE: The invasive tumor front (ITF) refers to cells or invasive nests in the junctional region of a tumor and its host. The ITF contains the most invasive cells of a tumor, and has a high prognostic value in carcinoma. The aim of this study is to investigate the epithelial-mesen...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000016/
https://www.ncbi.nlm.nih.gov/pubmed/24758906
http://dx.doi.org/10.3779/j.issn.1009-3419.2014.04.05
_version_ 1783331590465650688
collection PubMed
description BACKGROUND AND OBJECTIVE: The invasive tumor front (ITF) refers to cells or invasive nests in the junctional region of a tumor and its host. The ITF contains the most invasive cells of a tumor, and has a high prognostic value in carcinoma. The aim of this study is to investigate the epithelial-mesenchymal transformation phenotype in ITF cells of lung squamous cell carcinoma (SCC), and analyze the relationship between clinicopathological features and clinical outcomes of patients. METHODS: Semiquantitative immunohistochemistry was used to examine the expression of epithelial markers (E-cadherin and β-catenin) and mesenchymal marker (vimentin) in 104 lung SCC tumor tissues. RESULTS: A decrease in E-cadherin expression in ITF cells was observed in 56 of 104 (53.8%) tumors from patients. This result was markedly lower than that of non-ITF cells, which eventually developed metastatic tumors and were also associated with death (P=0.04). Vimentin expression was observed in 44 of 104 (42.3%) ITF cells, which was much higher than that of non-ITF cells. The downregulation of E-cadherin and overexpression of vimentin were associated with tumor invasive pattern, lymphatic metastasis, and poor prognosis (P < 0.01). The expression of β-catenin was 67.3% (70/104) in ITF cells. Moreover, ITF cells showed more nuclear and plasma-positive cells, which were closely associated with metastasis (P < 0.01). CONCLUSION: The loss in expression of E-cadherin/β-catenin and overexpression of vimentin in ITF cells may be associated with poor prognosis of lung SCC patients.
format Online
Article
Text
id pubmed-6000016
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-60000162018-07-06 肺鳞癌肿瘤浸润前沿细胞的EMT表型特点及临床意义 Zhongguo Fei Ai Za Zhi 临床研究 BACKGROUND AND OBJECTIVE: The invasive tumor front (ITF) refers to cells or invasive nests in the junctional region of a tumor and its host. The ITF contains the most invasive cells of a tumor, and has a high prognostic value in carcinoma. The aim of this study is to investigate the epithelial-mesenchymal transformation phenotype in ITF cells of lung squamous cell carcinoma (SCC), and analyze the relationship between clinicopathological features and clinical outcomes of patients. METHODS: Semiquantitative immunohistochemistry was used to examine the expression of epithelial markers (E-cadherin and β-catenin) and mesenchymal marker (vimentin) in 104 lung SCC tumor tissues. RESULTS: A decrease in E-cadherin expression in ITF cells was observed in 56 of 104 (53.8%) tumors from patients. This result was markedly lower than that of non-ITF cells, which eventually developed metastatic tumors and were also associated with death (P=0.04). Vimentin expression was observed in 44 of 104 (42.3%) ITF cells, which was much higher than that of non-ITF cells. The downregulation of E-cadherin and overexpression of vimentin were associated with tumor invasive pattern, lymphatic metastasis, and poor prognosis (P < 0.01). The expression of β-catenin was 67.3% (70/104) in ITF cells. Moreover, ITF cells showed more nuclear and plasma-positive cells, which were closely associated with metastasis (P < 0.01). CONCLUSION: The loss in expression of E-cadherin/β-catenin and overexpression of vimentin in ITF cells may be associated with poor prognosis of lung SCC patients. 中国肺癌杂志编辑部 2014-04-20 /pmc/articles/PMC6000016/ /pubmed/24758906 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.04.05 Text en 版权所有©《中国肺癌杂志》编辑部2014 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 临床研究
肺鳞癌肿瘤浸润前沿细胞的EMT表型特点及临床意义
title 肺鳞癌肿瘤浸润前沿细胞的EMT表型特点及临床意义
title_full 肺鳞癌肿瘤浸润前沿细胞的EMT表型特点及临床意义
title_fullStr 肺鳞癌肿瘤浸润前沿细胞的EMT表型特点及临床意义
title_full_unstemmed 肺鳞癌肿瘤浸润前沿细胞的EMT表型特点及临床意义
title_short 肺鳞癌肿瘤浸润前沿细胞的EMT表型特点及临床意义
title_sort 肺鳞癌肿瘤浸润前沿细胞的emt表型特点及临床意义
topic 临床研究
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000016/
https://www.ncbi.nlm.nih.gov/pubmed/24758906
http://dx.doi.org/10.3779/j.issn.1009-3419.2014.04.05
work_keys_str_mv AT fèilínáizhǒngliújìnrùnqiányánxìbāodeemtbiǎoxíngtèdiǎnjílínchuángyìyì
AT fèilínáizhǒngliújìnrùnqiányánxìbāodeemtbiǎoxíngtèdiǎnjílínchuángyìyì
AT fèilínáizhǒngliújìnrùnqiányánxìbāodeemtbiǎoxíngtèdiǎnjílínchuángyìyì
AT fèilínáizhǒngliújìnrùnqiányánxìbāodeemtbiǎoxíngtèdiǎnjílínchuángyìyì
AT fèilínáizhǒngliújìnrùnqiányánxìbāodeemtbiǎoxíngtèdiǎnjílínchuángyìyì
AT fèilínáizhǒngliújìnrùnqiányánxìbāodeemtbiǎoxíngtèdiǎnjílínchuángyìyì